Literature DB >> 16687877

Seroprevalence of hepatitis B, hepatitis C and human immunodeficiency viruses amongst drug users in Amritsar.

R Tiwari, A Aggarwal, P Devi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16687877     DOI: 10.4103/0255-0857.25223

Source DB:  PubMed          Journal:  Indian J Med Microbiol        ISSN: 0255-0857            Impact factor:   0.985


× No keyword cloud information.
  6 in total

Review 1.  Overview of substance abuse and hepatitis C virus infection and co-infections in India.

Authors:  Debasish Basu
Journal:  J Neuroimmune Pharmacol       Date:  2010-06-19       Impact factor: 4.147

2.  Quality of life assessment of patients with chronic liver disease in eastern India using a Bengali translation chronic liver disease questionnaire.

Authors:  Irene Ray; Deep Dutta; Pallavi Basu; Binay K De
Journal:  Indian J Gastroenterol       Date:  2010-08-26

3.  Seroprevalence of HIV Among Intravenous Drug Users in Amritsar: Risk Factors and Risk Behavior.

Authors:  Usha Arora
Journal:  J Lab Physicians       Date:  2009-07

4.  The intersection between sex and drugs: a cross-sectional study among the spouses of injection drug users in Chennai, India.

Authors:  Sunil S Solomon; Aylur K Srikrishnan; David D Celentano; Sethulakshmi C Johnson; Canjeevaram K Vasudevan; Kailapuri G Murugavel; Santhanam Anand; M Suresh Kumar; Suniti Solomon; Shruti H Mehta
Journal:  BMC Public Health       Date:  2011-01-16       Impact factor: 3.295

5.  Hepatitis C virus (HCV) infection & risk factors for HCV positivity in injecting & non-injecting drug users attending a de-addiction centre in northern India.

Authors:  Debasish Basu; Arun Kumar Sharma; Sunil Gupta; Naresh Nebhinani; Vineet Kumar
Journal:  Indian J Med Res       Date:  2015-09       Impact factor: 2.375

6.  Hepatitis B and C Viruses, Their Coinfection and Correlations in Chronic Liver Disease Patients: A Tertiary Care Hospital Study.

Authors:  Udhayvir Singh Grewal; Geeta Walia; Rupinder Bakshi; Siddharth Chopra
Journal:  Int J Appl Basic Med Res       Date:  2018 Oct-Dec
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.